Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-16-106698
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-21 21:32:27
Reporting Period:
2016-03-21
Filing Date:
2016-03-21
Accepted Time:
2016-03-21 21:32:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157602 Vitae Pharmaceuticals Inc VTAE Pharmaceutical Preparations (2834) 043567753
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202285 Jr J Donald Hayden C/o Vitae Pharmaceuticals, Inc.
502 West Office Center Dr.
Fort Washington PA 19034
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-21 1,935 $3.45 1,935 No 4 M Direct
Common Stock Acquisiton 2016-03-21 14,195 $3.45 14,195 No 4 M Direct
Common Stock Disposition 2016-03-21 16,130 $7.42 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-03-21 1,935 $0.00 1,935 $3.45
Common Stock Stock Option (Right to Buy) Disposition 2016-03-21 14,195 $0.00 14,195 $3.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-03-28 No 4 M Direct
0 2016-03-28 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2015.
  2. The option vested over three years of service following March 29, 2006, with 50% vesting upon completion of one year of service and in 2 equal annual installments thereafter.
  3. The option vested over four years of service following March 29, 2006, with 25% vesting upon completion of one year of service and in 36 equal monthly installments thereafter.